MENU
+Compare
RDY
Stock ticker: NYSE
AS OF
Jul 25 closing price
Price
$14.67
Change
-$0.04 (-0.27%)
Capitalization
12.48B

RDY Dr. Reddy's Laboratories Ltd Forecast, Technical & Fundamental Analysis

RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RDY with price predictions
Jul 25, 2025

RDY sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for RDY moved above the 200-day moving average on June 26, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where RDY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 24, 2025. You may want to consider a long position or call options on RDY as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for RDY turned negative on June 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

RDY moved below its 50-day moving average on July 10, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RDY crossed bearishly below the 50-day moving average on July 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RDY entered a downward trend on July 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RDY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.833) is normal, around the industry mean (62.701). P/E Ratio (19.682) is within average values for comparable stocks, (88.783). Projected Growth (PEG Ratio) (4.879) is also within normal values, averaging (2.913). Dividend Yield (0.007) settles around the average of (0.122) among similar stocks. P/S Ratio (3.786) is also within normal values, averaging (18.372).

View a ticker or compare two or three
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RDY is expected to report earnings to rise 12.55% to 22 cents per share on October 24

Dr. Reddy's Laboratories Ltd RDY Stock Earnings Reports
Q3'25
Est.
$0.23
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.03
The last earnings report on July 23 showed earnings per share of 20 cents, missing the estimate of 20 cents. With 1.11M shares outstanding, the current market capitalization sits at 12.48B.
A.I.Advisor
published Dividends

RDY paid dividends on August 12, 2024

Dr. Reddy's Laboratories Ltd RDY Stock Dividends
А dividend of $4.78 per share was paid with a record date of August 12, 2024, and an ex-dividend date of July 30, 2024. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CPNS26.540.02
+0.06%
Calamos Nasdaq-100 Str Alt Prt ETF-Sep
TIPX19.12N/A
N/A
SPDR® Blmbg 1-10 Year TIPS ETF
JJGTF26.00N/A
N/A
Barclays Bank PLC
AGOX29.87N/A
N/A
Adaptive Alpha Opportunities ETF
RIGS22.96-0.32
-1.39%
RiverFront Strategic Income ETF

RDY and Stocks

Correlation & Price change

A.I.dvisor tells us that RDY and COLL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and COLL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+0.36%
COLL - RDY
31%
Poorly correlated
-1.03%
AMPH - RDY
28%
Poorly correlated
-1.15%
HROW - RDY
26%
Poorly correlated
-2.81%
OGI - RDY
26%
Poorly correlated
+1.32%
VTRS - RDY
26%
Poorly correlated
+0.64%
More